Pancreatic cancer remains one of the most discussed and urgently addressed areas in oncology drug development. A clear-eyed Pancreatic Cancer Drug Pipeline Analysis helps clinicians, investors, and healthcare strategists understand where therapeutic innovation is heading and what practical options might reach patients. This article walks through the therapy landscape, the technologies shaping...